Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), utilizing vaginal-fluid specimens, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, when reported

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 81515 pertains to a molecular diagnostic procedure that utilizes real-time polymerase chain reaction (PCR) amplification to identify specific DNA markers associated with bacterial vaginosis and vaginitis. This procedure is particularly focused on detecting DNA sequences unique to certain bacterial species, including Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis Associated Bacteria-2 (BVAB-2). The analysis is performed on vaginal fluid specimens, which are collected and processed to assess the presence of these markers. Real-time PCR is a sophisticated technique that not only amplifies the target DNA but also allows for the quantification of the DNA present in the sample, providing either quantitative or semi-quantitative results. The process involves an enzyme reaction that facilitates the amplification of the DNA, and fluorescence measurements are taken after each cycle to monitor the amount of DNA being amplified. This method is particularly valuable in diagnosing bacterial vaginosis, a condition characterized by an imbalance in the normal bacterial flora of the vagina. Additionally, the procedure includes the separate detection of Trichomonas vaginalis and various Candida species, such as Candida albicans, Candida tropicalis, Candida parapsilosis, Candida dubliniensis, as well as Candida glabrata and Candida krusei, when reported. The algorithm used in this testing provides a clear positive or negative result, indicating a high likelihood of bacterial vaginosis based on the detected DNA markers.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 81515 is indicated for the diagnosis of bacterial vaginosis and vaginitis. The following conditions and symptoms may warrant the use of this molecular diagnostic tool:

  • Bacterial Vaginosis - A condition characterized by an imbalance in the normal bacterial flora of the vagina, often leading to symptoms such as unusual vaginal discharge, odor, and irritation.
  • Vaginitis - Inflammation of the vagina that can result from various causes, including infections, which may present with symptoms like itching, burning, and abnormal discharge.
  • Presence of Specific Bacteria - The detection of DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and BVAB-2 is crucial for confirming bacterial vaginosis.
  • Trichomonas Vaginalis Infection - The procedure allows for the identification of Trichomonas vaginalis, a common sexually transmitted infection that can cause vaginitis.
  • Candida Species Infection - The detection of various Candida species, including Candida albicans and others, is important for diagnosing yeast infections that may present with similar symptoms.

2. Procedure

The procedure for CPT® Code 81515 involves several key steps to ensure accurate diagnosis through real-time PCR amplification:

  • Sample Collection - A sample of vaginal fluid is collected from the patient. This specimen is critical as it contains the DNA markers necessary for the analysis.
  • DNA Extraction - The collected vaginal fluid undergoes a process of DNA extraction to isolate the target DNA sequences from the sample. This step is essential for the subsequent amplification process.
  • Real-Time PCR Amplification - The extracted DNA is subjected to real-time PCR amplification. This involves the use of specific primers that bind to the DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and BVAB-2. The amplification process is monitored in real-time using fluorescence measurements, allowing for the quantification of the DNA present.
  • Detection of Additional Pathogens - In addition to the primary markers, the procedure also includes the separate detection of Trichomonas vaginalis and various Candida species. This is achieved through the same amplification process, ensuring comprehensive testing for common pathogens associated with vaginitis.
  • Result Interpretation - After amplification, the results are analyzed and reported as either positive or negative for a high likelihood of bacterial vaginosis. The algorithm used in this analysis provides clarity on the presence of the detected DNA markers.

3. Post-Procedure

Post-procedure care following the testing associated with CPT® Code 81515 typically involves the communication of results to the patient and the healthcare provider. If the results indicate a positive diagnosis for bacterial vaginosis or any detected infections, appropriate treatment options should be discussed. Patients may be advised on follow-up appointments to monitor symptoms and response to treatment. Additionally, education on preventive measures and the importance of follow-up testing may be provided to ensure comprehensive care and management of the condition.

Short Descr NFCT DS BV&VAGINITIS DNA ALG
Medium Descr NFCT DS BV&VAGINITIS RTPCR AMP DNA MARKERS
Long Descr Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), utilizing vaginal-fluid specimens, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, when reported
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) Yes
APC Status Indicator Service Paid under Fee Schedule or Payment System other than OPPS
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
Date
Action
Notes
2025-01-01 Added Code Added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"